anika_new_logo_highres_360x133 (002) (1).png
Anika Announces Planned CFO Transition
June 02, 2020 16:05 ET | Anika Therapeutics Inc.
Sylvia Cheung to Step Down in August 2020 Company Initiates Search for Successor BEDFORD, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports First Quarter 2020 Financial Results
May 07, 2020 16:05 ET | Anika Therapeutics Inc.
Total Revenue Increases 43% Year-over-YearContinued Progress on Integration of Parcus Medical and Arthrosurface AcquisitionsWithdrawing Full Year 2020 Financial Guidance Well Positioned to Manage...
anika_new_logo_highres_360x133 (002) (1).png
Anika Takes Actions to Strengthen Liquidity in Light of COVID-19
April 08, 2020 16:05 ET | Anika Therapeutics Inc.
BEDFORD, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Fourth Quarter and Full Year 2019 Financial Results
February 20, 2020 16:05 ET | Anika Therapeutics Inc.
Total Revenue Increases 10% Year-over-Year for the Fourth QuarterCompletes Acquisitions of Parcus Medical and ArthrosurfaceCompany Expects Total Revenue Growth in the 40% to 44% Range for Full Year...
anika_new_logo_highres_360x133 (002) (1).png
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
February 12, 2020 16:05 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company’s Board of Directors since August 2018,...
anika_new_logo_highres_360x133 (002) (1).png
Anika Therapeutics Closes Acquisition of Arthrosurface
February 03, 2020 16:30 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
JDarling_2048px
Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer
January 29, 2020 16:30 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) announced today with great sadness that Joseph Darling, its President and Chief Executive Officer, passed...
Anika2019-RGB.jpg
Anika Therapeutics Closes Acquisition of Parcus Medical
January 24, 2020 16:05 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Jan. 24, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its...
anika_new_logo_highres_360x133 (002) (1).png
Anika to Showcase Commercial and Pipeline Portfolio at 2018 AAOS Annual Meeting
March 06, 2018 07:00 ET | Anika Therapeutics Inc.
BEDFORD, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary...
anika_new_logo_highres_360x133 (002) (1).png
Joseph Darling Named CEO and Director of Anika Therapeutics
March 05, 2018 16:02 ET | Anika Therapeutics Inc.
BEDFORD, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the appointment of Joseph Darling as Chief Executive Officer, succeeding Dr. Charles...